文献速递临床试验与 GCP基础与转化研究

维生素D与ω-3脂肪酸联合补充对结直肠癌患者炎症标志物、肿瘤标志物CEA及营养状况的影响:双盲随机对照试验研究方案

Effects of vitamin D and omega-3 fatty acids co-supplementation on inflammatory biomarkers, tumor marker CEA, and nutritional status in patients with colorectal cancer: a study protocol for a double blind randomized controlled trial.
PubMed 文献 · Trials · 2019-12-09

本研究为一项为期8周的双盲随机安慰剂对照临床试验方案,旨在评估维生素D与ω-3脂肪酸联合补充对接受化疗的II期或III期结直肠癌患者炎症标志物、肿瘤标志物CEA及营养状况的影响。基于动物实验和观察性研究提示两者可抑制结肠癌变、降低炎症标志物并改善生存,研究假设联合补充可能作为新的辅助治疗减少炎症和肿瘤治疗抵抗。

要点

  • 维生素D与ω-3脂肪酸联合补充可能降低结直肠癌患者炎症标志物。
  • 干预为期8周,对象为接受化疗的II/III期结直肠癌患者。
  • 主要关注炎症标志物、肿瘤标志物CEA及营养状况的变化。

核心结论

  • 维生素D与ω-3脂肪酸联合补充可能通过降低炎症标志物和肿瘤治疗抵抗,为结直肠癌患者提供新的辅助治疗选择。

研究设计与样本

  • 为期8周的双盲随机安慰剂对照临床试验,纳入接受化疗的II期或III期结直肠癌患者。
  • 试验已在伊朗临床试验注册中心注册(IRCT20180306038979N1),注册日期2018年3月16日。

临床怎么用

  • 该方案尚处于研究阶段,结果未报告,暂不能形成临床推荐。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Much evidence is available demonstrating that both vitamin D and omega-3 fatty acids block the development and progression of colonic carcinogenesis. The results of animal studies have shown that the consumption of omega-3 fatty acids can decrease inflammatory biomarkers, enhance the efficacy of chemotherapy, and decrease the side effects of chemotherapy or cancer. Also, observational studies propose that higher levels of 25(OH)D are related to improved survival of colorectal cancer patients. This study will aim to evaluate the effects of vitamin D and omega-3 fatty acids co-supplementation on inflammatory biomarkers, tumor marker CEA, and nutritional status in colorectal cancer patients. METHODS/DESIGN: We will carry out an 8-week double-blind randomized, placebo-controlled clinical trial to evaluate the effects of vitamin D and omega-3 fatty acids co-supplementation on inflammatory biomarkers, tumor marker CEA, and nutritional status in patients with stage ӀӀ or ӀӀӀ colorectal cancer undergoing chemotherapy. DISCUSSION: Because of the important effects of vitamin D and omega-3 fatty acids on molecular pathways involved in cancer development and progression, it seems that both vitamin D and omega-3 fatty acids may provide a new adjuvant therapy by decreasing inflammatory biomarkers and resistance to cancer treatment in patients with colorectal cancer. TRIAL REGISTRATION: Iranian Registry of Clinical Trials IRCT20180306038979N1. Registered on 16 March 2018.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Haidari F, Abiri B, Iravani M, et al. Effects of vitamin D and omega-3 fatty acids co-supplementation on inflammatory biomarkers, tumor marker CEA, and nutritional status in patients with colorectal cancer: a study protocol for a double blind randomized controlled trial. Trials. 2019. PMID: 31815661. doi:10.1186/s13063-019-3719-3

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。